Table 1. Consequences of mutations that occur in AGS patients on ADAR1 functions.
The first column lists the mutations with normal amino acid followed by the amino acid location in the human ADAR1 p150 isoform followed by the mutant amino acid. The domain location as well as the type of inheritance are indicated. Known effects of the mutations on RNA editing and possible ADAR1 functions are provided (Mannion et al., 2014; Rice et al., 2012).
Identified variants of human ADAR1 that occur in AGS patients | ||||
---|---|---|---|---|
Mutation | Location | Disease Description | Effect on editing | Predicted effect on molecular function |
A870T | – | ![]() |
No significant reduction | Protein destabilization |
I872T | – | Compound heterozygote with P193A mutation | No significant reduction | Protein destabilization |
R892H | Deaminase | ![]() |
No significant reduction | Disruption of protein interactions with dsRNA |
K999N | Deaminase (RNA binding loop) | Autosomal recessive | No significant reduction | – |
G1007R | Deaminase (RNA binding loop) | Autosomal dominant | Significant reduction | Potential competitive inhibitor of WT ADAR1 protein |
Y1112H | Deaminase | Autosomal recessive | Not tested | – |
D1113H | Deaminase | Autosomal recessive | No significant reduction | – |